WGRX

Trading under new symbol (NASDAQ:MEDS) completes corporate rebranding from prior corporate name Wellgistics Health (NASDAQ:WGRX) TAMPA, FL / ACCESS Newswire / July 22, 2026 / DataMEDS AI, Inc., (NASDAQ:MEDS, "DataMEDS, " or the "Company")), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to provide integrated solutions for the generation, rationalization, intervention, transaction and monetization of health data, today announced that it has officially completed its stock trading symbol change to 'MEDS'. The Company began trading under the new stock symbol 'MEDS' on the NASDAQ Capital Market stock ex

8-K - Wellgistics Health, Inc. (0002030763) (Filer)

Leading Health IT Company's Rebranding Reflects Updated Healthcare Ecosystem Aligned with AI Integration to Optimize Patient Control of Healthcare DataTAMPA, Fla., July 21, 2026 /PRNewswire/ -- Wellgistics Health, Inc., (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that it has officially completed its name change to  DataMEDS AI, Inc. ("DataMEDS" or  "the Company"). Simultaneous with this announcement, the Company announced that it will begin trading under the stock symbol 'MEDS' on the NASDAQ Capital Market stock exchange on Wednesday, July 22, 2026.

TAMPA, FL / ACCESS Newswire / July 20, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader implementing EinsteinRx™ artificial intelligence prescription drug routing into blockchain-enabled smart contracts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey, today announced an updated record date for the distribution of the Dream Bowl 2026 Meme Coin (https://www.biconomy.com/exchange/DREAM1_USDT) to Wellgistics stockholders. On December 3, 2025, Wellgistics announced that it would distribute one (1) Dream Bowl 2026 Meme Coin for every one (1) share of Wellgistics Health common stock held as of a

NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Rubenstein Public Relations (RPR), a leading full-service communications firm, announces it has been named the Agency of Record for Wellgistics Health, Inc. (NASDAQ:WGRX), a Tampa based health IT company, ahead of their planned reorganization to an AI-integrated healthcare ecosystem. RPR will drive a comprehensive communications campaign to support thought leadership, public positioning, and amplify licensed technologies under a consolidated portfolio of brands. Wellgistics Health, which developed the pharmacy dispensing artificial intelligence platform EinsteinRx™, will expand this proprietary technology into the medical, laboratory and wearabl

Experienced Healthcare Information Technology Specialist Joins Leading Pharmaceutical IT Company TAMPA, FL / ACCESS Newswire / July 15, 2026 / Wellgistics Health, Inc. (the "Company" or "Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that it appointed healthcare information technology executive Brett Thompson as the Company's consulting Chief Technology Officer (CTO). Mr. Thompson has more than thirty years of experience designing, developing, and leading enterprise software solutions, including more than seventeen years focused on healthcare and pharmacy

Executives exercise previously issued warrants to acquire 200,000 common sharesShares issued in connection with exercise added to existing lock-up agreements TAMPA, FL / ACCESS Newswire / June 30, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that its Executive Chairman Suren Ajjarapu and President & Interim Co-CEO Prashant Patel have exercised all warrants previously issued to them in connection with the conversion of their outstanding salaries into common shares at $10 per share. The exercise of the warrants resulted in

Name reflects vertically-aligned healthcare ecosystem business model integrating data captured via telemedicine, online pharmacy, lab tests and wearables to perfect patients' digital health twins in the Health Lives Here app designed to influence/optimize behaviorEinsteinRx AI™ capabilities expanding into medical, laboratory and wearables fieldsPharmacy and Pharmacy Services division being rebranded as Corexa Health™Company positioned to empower patients to seize ownership of their health data with blockchain-enabled data management to control data and participate in its monetization(1) 2,647,198 common shares outstanding, with (2) 1,333,930 of those shares locked up for at least ninety (90)

4 - Wellgistics Health, Inc. (0002030763) (Issuer)

4 - Wellgistics Health, Inc. (0002030763) (Issuer)

4/A - Wellgistics Health, Inc. (0002030763) (Issuer)

4/A - Wellgistics Health, Inc. (0002030763) (Issuer)

PRE 14A - Wellgistics Health, Inc. (0002030763) (Filer)

8-K - Wellgistics Health, Inc. (0002030763) (Filer)

8-K/A - Wellgistics Health, Inc. (0002030763) (Filer)

8-K/A - Wellgistics Health, Inc. (0002030763) (Filer)

Focus is on closing DelivMeds AI transaction, driving pharmacy revenue growth and supporting PharmacyChain™, Medical Drones and Health Lives Here progressRecent capital raise provides capital into late 2026, including meeting criteria for DelivMeds AI transaction funding closing conditionRecent capital raise and debt restructuring preclude the Company from issuing shares for capital raising purposes until the earlier of seven (7) months from the transaction date and thirty (30) days after effectiveness of the resale registration statement covering the underlying securities.Recent lock-up agreement to limit shares available for sale into the marketExercise of warrants embedded in recent finan

8-K - Wellgistics Health, Inc. (0002030763) (Filer)

Holders of 1,333,930 common shares agree to minimum 90-day lock-up agreement TAMPA, FL / ACCESS Newswire / May 28, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that holders of a 1,333,930 common shares, representing a majority of the outstanding common shares of the Company, have entered into a lock-up agreement that precludes the sale of their shares into the market for at least 90 days."This lock-up agreement, when combined with the recent restructuring of our convertible liabilities and the raising of new funding, und

New oversubscribed $21 million convertible debt instrument ("New Debt") refinances all outstanding convertible debt, provides $6.5 million in new capital for working capital and general corporate purposes does not accrue interest and converts into common shares at $6.00 per shareAutomatic Exchange provision automatically converts the New Debt into Preferred Stock upon the effectiveness of a registration statement and attainment of shareholder approval for the creation of Preferred StockThe class of Preferred Stock that the New Convertible Debt exchanges into (the "Funding Preferred") converts into common shares at $50.00 per shareNew funds raised satisfy capital raising closing condition fro

1-for-50 reverse split of common shares outstanding now complete2,513,425 common shares now outstandingA new CUSIP was issued in connection with reverse split TAMPA, FL / ACCESS Newswire / May 26, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that it completed a 1-for-50 reverse stock split (the "Reverse Split") of the Company's common stock, par value $0.00001 per share (the "Common Stock"). The Reverse Split was approved by a majority of the stockholders of the Company on April 2, 2026. The Common Stock is now trading u

8-K - Wellgistics Health, Inc. (0002030763) (Filer)

This Press Release updates the information from the previous release.Why Vertical Integration and Blockchain Will Define the Next Era of Healthcare TAMPA, FL / ACCESS Newswire / May 21, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today released a letter to shareholders expanding upon the strategy behind recently announced transactions.'Dear Fellow Shareholders,Yesterday we announced a series of transactions that, taken together, mark the most consequen

Why Vertical Integration and Blockchain Will Define the Next Era of Healthcare PHILADELPHIA, PA / ACCESS Newswire / May 21, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company"), a provider of data monetization, credentialing, digital engagement, and real-world asset ('RWA') tokenization technologies, today entered into a fully binding term sheet (the "Binding Term Sheet") with Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today released a letter to shareh

8-K - Wellgistics Health, Inc. (0002030763) (Filer)